VA Partners I, LLC
CIK 1418812 · last filed 2025-12-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MSFT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, 4TH FLOOR
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRM | Director | 2,995,617 | $241.29 | $722.81M | $998.50M | 3 | 2025-12-08 |
| NSIT | Director | 4,061,739 | $178.44 | $724.78M | -$348.02M | 7 | 2024-05-31 |
| FISV | Director | 7,549,318 | $47.40 | $357.80M | -$1.15B | 5 | 2023-08-09 |
| Altus Power, Inc. (AMPS) Delisted | Director | 4,032,622 | $4.99 | $20.12M | $0 | 2 | 2023-02-09 |
| Altus Power, Inc. (AMPS.WS) Delisted | Director | 4,017,520 | $2.89 | $11.61M | $0 | 1 | 2022-04-20 |
| TRN | Director | 93,749 | $25.43 | $2.38M | -$1.72B | 14 | 2022-02-24 |
| STX | Director | 13,737,070 | $671.34 | $9.22B | -$1.50B | 7 | 2022-02-22 |
| AES | Director | 4,846,500 | $15.03 | $72.84M | $71.08M | 3 | 2020-05-19 |
| HE | Director | 2,012,252 | $8.30 | $16.71M | $558.56M | 1 | 2020-03-13 |
| UFI | Director | 1,418,896 | $5.55 | $7.87M | $7.91M | 3 | 2019-11-01 |
| CBRE | Director | 10,234,261 | $121.84 | $1.25B | -$1.29B | 2 | 2019-09-16 |
| AWI | Director | 7,295 | $155.19 | $1.13M | -$51.49M | 4 | 2019-05-03 |
| BREAD FINANCIAL HOLDINGS, INC. (ADS) Delisted | Director | 3,707,646 | $56.80 | $210.59M | -$561.44M | 4 | 2019-04-29 |
| CBRE GROUP, INC. (CBG) Delisted | Director | 24,926,042 | — | — | -$566.15M | 2 | 2017-11-30 |
| MSFT | Director | 8,132,114 | $532.20 | $4.33B | -$3.86B | 4 | 2017-11-30 |
| WILLIS TOWERS WATSON PLC (WLTW) Delisted | Director | 4,043,358 | $231.56 | $936.28M | -$224.74M | 1 | 2017-09-05 |
| MSCI | Director | 1,421,251 | $601.52 | $854.91M | -$1.37B | 5 | 2016-06-13 |
| ALSN | Director | 19,125,204 | $107.22 | $2.05B | $126.22M | 3 | 2016-06-07 |
| WILLIS TOWERS WATSON PLC (WSH) Delisted | Director | 6,956,749 | — | — | $0 | 1 | 2015-08-12 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 18,034,177 | — | — | -$536.13M | 8 | 2015-05-27 |
| MSI | Director | 17,597,079 | $484.54 | $8.53B | -$18.43M | 3 | 2015-05-20 |
| ADBE | Director | 16,306,753 | $248.18 | $4.05B | -$3.39B | 4 | 2014-12-29 |
| OPENLANE, Inc. (KAR) Delisted | 10%+ Owner | 8,845,045 | $30.88 | $273.13M | -$1.10B | 4 | 2013-08-15 |
| IT | Director | 1,648,434 | $219.97 | $362.61M | -$2.55B | 5 | 2011-12-13 |
| IMMUCOR INC (BLUD) Delisted | 10%+ Owner | 7,540,665 | — | — | $88.95M | 2 | 2010-07-27 |
| GEVITY HR INC (GVHR) Delisted | 10%+ Owner | 2,990,451 | — | — | $0 | 1 | 2009-05-26 |
Recent Filings · Page 11 of 11
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-07-15 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +900,000 | $20.96M | EDGAR |
| 2009-07-07 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +345,060 | $8.37M | EDGAR |
| 2009-06-18 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,366,344 | $31.42M | EDGAR |
| 2009-06-16 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +600,000 | $13.79M | EDGAR |
| 2009-06-09 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,250,346 | $28.84M | EDGAR |
| 2009-05-26 | GEVITY HR INC (GVHR) Delisted | Other (J) | +30,150 | $0 | EDGAR |
| 2008-06-02 | — | Grant (A) | — | $0 | |
| 2008-05-22 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +46,542 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.